Timpani Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Timpani Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-133,875	Closed	-$4.16M	–	106
2014 Q3	$4.16M	Buy	+133,875	New	+$3.63M	1.9%	15
2014 Q1	–	Sell	-144,893	Closed	-$3.68M	–	113
2013 Q4	$3.68M	Buy	144,893 +34,678	+31%	+$783K	1.83%	16
2013 Q3	$2.25M	Buy	+110,215	New	+$2.45M	1.33%	32

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Timpani Capital Management's SGNT Position: Q4 2014 in Review

Timpani Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2014, closing a stake of 133,875 shares — an estimated $4.16M sold.

Timpani Capital Management first reported a position in SGNT in Q3 2013 and held it in 3 quarters. The position peaked at $4.16M in Q3 2014. 131 funds tracked by Wall St. Rank hold SGNT as of Q4 2014.

Timpani Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Timpani Capital Management sold 133,875 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $4.16M.
Timpani Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
Timpani Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4.16M in Q3 2014.
131 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Timpani Capital Management's 13F filing for Q4 2014, filed 5 Feb 2015.